RESUMO
O Boletim Epidemiológico da Dengue é uma publicação e instrumento de gestão utilizado para o acompanhamento, análise e monitoramento da doença em todo Estado de Goiás. A estratégia permite mensurar a tendência da doença, assim como avaliar os riscos inerentes à essa enfermidade nos municípios goianos. Com isso é possível decidir sobre a execução de ações de controle do Aedes aegypti, envio de medicamentos, distribuição de insumos, entre outras ações. O Boletim é atualizado semanalmente pela equipe técnica da Coordenação Estadual de Controle de Dengue, Zika Vírus e Chikungunya da SES-GO.
The Dengue Epidemiological Bulletin is a publication and management tool used for the monitoring, analysis and monitoring of the disease throughout the State of Goiás. The strategy allows measuring the trend of the disease, as well as evaluating the risks inherent to this disease in the municipalities of Goia. With this it is possible to decide on the execution of control actions of Aedes aegypti, sending of medicines, distribution of inputs, among other actions. The Bulletin is updated weekly by the technical team of the State Coordination of Dengue, Zika Virus and Chikungunya Control of SES-GO.
Assuntos
Humanos , Masculino , Feminino , Dengue/epidemiologia , Brasil/epidemiologia , Incidência , Dengue/mortalidadeRESUMO
This study aims to provide a preliminary estimate of the immediate cost of chikungunya and dengue to household in the Indian state of Gujarat. Combining nine earlier studies and data from interviews, we analysed the costs of non-fatal illness and of intervention programmes; building a more comprehensive picture of the immediate cost of these Aedes aegypti mosquito-borne diseases to Gujarat. The “RUHA matrix” was used to estimate the cost of illness by combining the shares of reported (R) and unreported (U) hospitalized (H) and ambulatory (A) cases of chikungunya and dengue with ambulatory and hospitalization costs per case and the number of reported cases. Using Monte Carlo sensitivity analysis, the immediate cost to households incurred on account of chikungunya and dengue to Gujarat was estimated to be 3.8 (range 1.6–9.1) billion Indian rupees (INR) per annum (US$ 90 million, range US$ 38 and US$ 217 million). It is hoped that this preliminary estimate will trigger more refined studies on cost of illness as well as cost-effectiveness of vaccines and other interventions to combat these neglected tropical diseases.
